BioCentury
ARTICLE | Clinical News

Brovana arformoterol tartrate: Phase II data

October 29, 2007 7:00 AM UTC

In an open-label Phase II trial in 39 patients, 15 µg of Brovana showed improvements in FEV1 that were similar to racemic formoterol. Data were presented at the American College of Chest Physicians me...